SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
American States Water Company disclosed second quarter 2026 earnings on August 5, 2026, reporting diluted EPS of $1.09 compared to $0.87 in Q2 2025—a 25.3% increase. The press release, attached as Exhibit 99.1, provides detailed segment-level earnings analysis, year-to-date results, and forward guidance. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →STERIS issued a press release on August 5, 2026 announcing financial results for fiscal 2027 first quarter ended June 30, 2026, with revenue growth of 7% to $1.5 billion, diluted EPS of $2.04 (adjusted EPS of $2.59), and segment-level performance metrics across Healthcare, AST, and Life Sciences divisions.
View raw filing on EDGAR →Orion S.A. issued a press release on August 5, 2026 announcing its second quarter 2026 earnings results, including net sales of $501 million, net income of $2 million, and Adjusted EBITDA of $58 million. The press release is attached as Exhibit 99.1 and contains detailed financial results, segment performance, cash flow metrics, and updated full-year guidance. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →Murphy Oil Corporation issued a news release on August 5, 2026 announcing its financial and operating results for the quarter ended June 30, 2026, disclosing net income of $232.2 million, diluted EPS of $1.59, production of 169,000 BOEPD, and capital expenditures of $476 million. The full text of the earnings release is attached as Exhibit 99.1, which is the standard format for Item 2.02 earnings disclosures.
View raw filing on EDGAR →Centrus Energy issued a press release on August 5, 2026, announcing financial results for Q2 2026 (quarter ended June 30, 2026), including revenue of $176.1 million, GAAP net income of $16.8 million, and adjusted net income of $38.7 million. The disclosure includes detailed financial statements, segment performance, backlog information, and updated 2026 guidance. This is a standard quarterly earnings release furnished under Item 2.02 and is material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →CACI disclosed its financial results for the fourth quarter and full year ended June 30, 2026 via a press release furnished as Exhibit 99.1. The disclosure includes annual revenues of $9.6 billion (up 10.9% YoY), net income of $535.8 million, diluted EPS of $24.16 (up 8.2% YoY), and fiscal 2027 guidance. This is a standard earnings release under Item 2.02 that would materially affect a reasonable investor's assessment of the company's financial performance and outlook.
View raw filing on EDGAR →This is a press release announcing Ero Copper's second quarter 2026 operating and financial results. The document discloses consolidated Q2 copper production (17,315 tonnes), gold production (20,553 ounces), cash flow from operations ($137.9 million), adjusted EBITDA ($144.0 million), and net income ($89.5 million per share $0.85 diluted), along with full-year 2026 guidance reaffirmation and updates. This is a classic earnings release event disclosing quarterly financial results.
View raw filing on EDGAR →SandRidge Energy issued a press release on August 5, 2026 announcing financial and operational results for the three and six-month periods ended June 30, 2026, including condensed consolidated financial statements, production data, capital expenditures, per-share earnings, and forward-looking guidance.
View raw filing on EDGAR →Cushman & Wakefield issued a press release on August 5, 2026 reporting Q2 2026 financial results with revenue of $2.8 billion (up 11%), net income of $52.7 million, and adjusted EPS of $0.35 (up 17%), while raising 2026 annual Adjusted EPS guidance to 18%-23% growth.
View raw filing on EDGAR →Kraft Heinz issued a press release on August 5, 2026 announcing second quarter 2026 financial results, including net sales of $6.3 billion (down 1.4%), operating loss of $6.4 billion (driven by $7.4 billion in non-cash impairment losses), and updated full-year 2026 guidance. The disclosure is a standard quarterly earnings announcement with detailed financial tables, segment performance, and forward guidance, furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →LivaNova issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing second-quarter revenue of $390.6 million (10.8% reported growth), diluted EPS of $1.93, and adjusted diluted EPS of $1.26, along with raised full-year 2026 guidance. The press release is attached as Exhibit 99.1 and constitutes a standard earnings disclosure under Item 2.02.
View raw filing on EDGAR →The RMR Group Inc. issued a summary press release and detailed earnings presentation on August 5, 2026, announcing financial results for the fiscal third quarter ended June 30, 2026. The disclosure includes key financial metrics (net income of $7.4 million, net income per share of $0.18, Adjusted EBITDA of $19.7 million, and Distributable Earnings per share of $0.48), Assets Under Management of $37.5 billion, and a quarterly dividend declaration of $0.45 per share. This is a standard quarterly earnings release with comprehensive financial results and supplemental information, clearly fitting the earnings_release category.
View raw filing on EDGAR →Vaxcyte issued a press release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 net loss of $284.3 million, R&D expenses of $267.9 million, and cash position of $2.5 billion. The filing explicitly states the press release is furnished as Exhibit 99.1 and incorporates financial statements showing operating results, which is the hallmark of an earnings release under Item 2.02.
View raw filing on EDGAR →Editas Medicine issued a press release on August 5, 2026 announcing financial results for the fiscal quarter ended June 30, 2026, including quarterly net loss of $18.2 million (versus $53.2 million in the prior year), revenue figures, operating expenses, cash position of $211.6 million, and business updates on the EDIT-401 program.
View raw filing on EDGAR →Zomedica issued a press release on August 5, 2026 announcing consolidated financial results for the three and six months ended June 30, 2026, disclosing record second-quarter revenue of $9.5 million (up 37% year-over-year), net loss reduced 49%, and $44.1 million in liquidity. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is the archetypal earnings_release event type.
View raw filing on EDGAR →Beyond Meat issued a press release on August 5, 2026 announcing its financial results for the second quarter ended June 27, 2026. The disclosure includes detailed financial highlights (net revenues of $68.8 million, gross profit of $5.9 million, net income of $16.4 million), channel-level revenue breakdowns, operating metrics, balance sheet data, and forward guidance for Q3 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is the designated Item for results of operations and financial condition.
View raw filing on EDGAR →Blue Owl Capital Corporation issued a press release on August 5, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing GAAP net investment income per share of $0.36, adjusted NII per share of $0.34, NAV per share of $14.26, and dividend declarations totaling $0.33 per share. This is a standard quarterly earnings release with comprehensive financial highlights and results of operations, material to investors assessing the company's financial performance and dividend coverage.
View raw filing on EDGAR →Permian Resources issued a press release on August 5, 2026 announcing its financial and operational results for Q2 2026, including production volumes of 376.4 MBoe/d, operating cash flow of $1,506 million, adjusted free cash flow of $751 million, capital expenditures of $521 million, and updated full-year 2026 guidance.
View raw filing on EDGAR →Bioventus issued a press release on August 5, 2026 announcing Q2 and six-month financial results for the period ended June 27, 2026, with revenue of $153.2 million (4% growth) and GAAP earnings of $0.47 per diluted share, while reaffirming full-year 2026 guidance.
View raw filing on EDGAR →Adient plc issued a news release on August 5, 2026 announcing financial results for the third quarter ended June 30, 2026. The disclosure includes condensed consolidated statements of income, financial position, and cash flows, along with segment results and non-GAAP reconciliations. This is a standard quarterly earnings release furnished as Exhibit 99.1, which is the typical mechanism for disclosing quarterly financial results under Item 2.02.
View raw filing on EDGAR →Valvoline issued a press release on August 5, 2026 announcing third-quarter financial results for the period ended June 30, 2026, including net revenues of $544.6 million (24% growth), income from continuing operations of $65.0 million (14% growth), diluted EPS of $0.51 (16% increase), and updated full-year guidance.
View raw filing on EDGAR →This is a clear earnings release disclosing Paysign's Q2 2026 financial results, including revenue of $28.25 million (up 48.1% YoY), net income of $6.76 million, and raised full-year 2026 guidance. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing explicitly states "we issued a press release regarding our financial results for the second quarter ended June 30, 2026."
View raw filing on EDGAR →Inseego issued a press release on August 5, 2026 disclosing preliminary financial results for Q2 2026 ended June 30, 2026, including revenue of $44.0 million, Adjusted EBITDA of $0.5 million, and GAAP Net Loss of $8.4 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes consolidated statements of operations, business highlights, and forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →Brighthouse Financial issued a news release on August 5, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing net income of $956 million ($16.53 per diluted share) and adjusted earnings of $258 million ($4.45 per diluted share). The release includes detailed segment results, sales figures, capital metrics, and investment income data. This is a standard quarterly earnings disclosure attached as Exhibit 99.1 and incorporated by reference in Item 2.02.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 (quarter ended June 30, 2026) filed on August 5, 2026. The disclosure includes condensed consolidated statements of operations showing collaboration revenue, operating expenses, net loss of $42.8 million, and balance sheet data with cash position of $223.0 million. The press release also provides clinical pipeline updates and forward-looking guidance on data readouts, which are typical components of a biotech earnings announcement.
View raw filing on EDGAR →Southwest Gas Holdings released summary financial information for the quarter and six months ended June 30, 2026, including net income, earnings per share, and operational highlights. The press release discloses Q2 2026 net income of $42.1 million ($0.58 per diluted share) and six-month net income of $180.5 million ($2.49 per diluted share), along with detailed reconciliations and segment performance. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →Magnolia Oil & Gas Corporation issued a press release on August 5, 2026, announcing its financial and operational results for the quarter ended June 30, 2026, including net income of $181.8 million ($0.97 per diluted share), adjusted EBITDAX of $370.3 million, and production volumes of 106.1 Mboe/d.
View raw filing on EDGAR →Black Diamond Therapeutics disclosed its financial results for the six months ended June 30, 2026 via a press release furnished as Exhibit 99.1 under Item 2.02. The filing includes consolidated balance sheet data, statements of operations with revenue and net loss figures, and cash position disclosures. This is a standard earnings release announcement for a clinical-stage company reporting quarterly/semi-annual financial results.
View raw filing on EDGAR →AbCellera issued a press release on August 5, 2026 announcing Q2 2026 financial results, including revenue of $4.1 million, net loss of $55.4 million, and cash balances of over $565 million, along with business updates on clinical programs and new collaborations with Jazz and Vertex.
View raw filing on EDGAR →Granite Point Mortgage Trust Inc. issued a press release on August 5, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026, including GAAP net loss of $(62.0) million per share, distributable earnings loss, balance sheet data, and portfolio metrics. This is a standard quarterly earnings disclosure filed under Item 2.02 with exhibits 99.1 and 99.2 attached, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →Ecovyst issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing Q2 2026 sales of $250.0 million (up 42% YoY), net income of $10.7 million, Adjusted EBITDA of $53.1 million (up 27% YoY), and raising full-year 2026 guidance for Adjusted EBITDA to $195–$207 million. This is a standard quarterly earnings release with material financial results and forward guidance, filed under Item 2.02.
View raw filing on EDGAR →This is a press release announcing GlobalFoundries' second quarter 2026 financial results, including revenue of $1.786 billion, gross margin of 28.3%, net income of $167 million, and diluted EPS of $0.30. The document presents consolidated statements of operations, balance sheet, and cash flows for the quarter ended June 30, 2026, along with forward guidance for Q3 2026. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →Hamilton Beach Brands issued a press release on August 5, 2026 announcing unaudited financial results for Q2 2026 ended June 30, 2026. The disclosure includes revenue of $142.6 million (up 11.6%), gross margin of 54.3%, operating profit of $43.2 million, and diluted EPS of $2.49, along with full consolidated financial statements and updated 2026 guidance. This is a standard quarterly earnings release furnished under Item 2.02.
View raw filing on EDGAR →Liberty Latin America issued a press release on August 5, 2026 announcing its operating and financial results for Q2 2026 (quarter ended June 30, 2026). The filing explicitly states the press release is furnished under Item 2.02 "Results of Operations and Financial Condition," and the exhibit contains comprehensive quarterly financial and operating highlights including revenue, operating income, Adjusted OIBDA, cash flow, and segment performance metrics. This is a standard quarterly earnings disclosure.
View raw filing on EDGAR →Adicet Bio announced its financial results for the quarter ended June 30, 2026, via press release furnished as Exhibit 99.1. The disclosure includes consolidated statements of operations showing Q2 2026 net loss of $21.4 million ($1.99 per share), R&D and G&A expenses, cash position of $118.2 million, and balance sheet information. This is a standard quarterly earnings release disclosure under Item 2.02, material to investors assessing the company's financial condition and cash runway.
View raw filing on EDGAR →Arcus Biosciences issued a press release on August 5, 2026 announcing financial results for the six months ended June 30, 2026, disclosing Q2 2026 revenues ($41 million), R&D expenses ($113 million), G&A expenses ($24 million), net loss ($91 million), and cash position ($775 million). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the full press release furnished as Exhibit 99.1, which is the standard format for earnings releases.
View raw filing on EDGAR →This is a clear earnings release for the second quarter and first six months of 2026. The press release discloses consolidated net income of $600K ($0.01 EPS) for Q2 2026 versus a net loss of $2.5M ($0.06 loss per share) in Q2 2025, and year-to-date EPS of $2.33 versus $2.11 in the prior year. The company also provides 2026 full-year EPS guidance (upper half of $2.95–$3.15 range) and reaffirms long-term growth targets. This is a material disclosure affecting investor assessment of financial performance and forward guidance.
View raw filing on EDGAR →This is a clear earnings release disclosing Elanco's second quarter 2026 financial results, including revenue of $1,368 million (10% YoY growth), adjusted net income of $174 million, and adjusted EPS of $0.34. The filing also provides updated full-year 2026 guidance with raised revenue, EBITDA, and EPS targets. The press release is dated August 5, 2026, and is attached as Exhibit 99.1 to Item 2.02, which is the standard Item for results of operations disclosures.
View raw filing on EDGAR →This is a quarterly earnings release for Q2 2026 filed under Item 2.02 (Results of Operation and Financial Condition). The release discloses second quarter revenues of $658.7 million (up 2% YoY), adjusted EBITDA of $145.9 million (up 5% YoY), and adjusted diluted EPS of $1.13 (up 5% YoY), along with detailed segment performance and cash flow metrics. The earnings release is attached as Exhibit 99.1 and constitutes the primary disclosure required by Item 2.02.
View raw filing on EDGAR →The filing discloses Walt Disney Co's quarterly financial results for Q3 fiscal 2026 (quarter ended June 27, 2026) via an earnings release furnished as Exhibit 99.1. The release presents summarized financial results including revenues ($25.2 billion, up 7%), income before income taxes ($3.6 billion, up 14%), total segment operating income ($5.6 billion, up 21%), and adjusted EPS ($2.06, up 28%), along with segment-level performance and forward guidance for fiscal 2026 and 2027. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →Blue Owl Technology Finance Corp. issued a press release on August 5, 2026 announcing its financial results for the second quarter ended June 30, 2026. The disclosure includes GAAP net investment income per share of $0.30, adjusted NII per share of $0.30, NAV per share of $16.48, portfolio composition, investment activity, and detailed results of operations. This is a standard quarterly earnings release for a BDC, material to investors assessing the company's financial performance and position.
View raw filing on EDGAR →AppLovin issued a press release on August 5, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing revenue of $1,924 million (53% YoY growth), net income of $1,267 million (55% YoY growth), and Adjusted EBITDA of $1,614 million (58% YoY growth), along with Q3 2026 guidance. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →Envista issued a press release on August 5, 2026 announcing Q2 2026 financial results for the quarter ended July 3, 2026, with Q2 sales of $731 million (5.0% core growth), adjusted diluted EPS of $0.41 (+58% YoY), and adjusted EBITDA of $108 million (+28% YoY), along with raised full-year 2026 guidance for core sales growth, adjusted EBITDA, and adjusted EPS.
View raw filing on EDGAR →Mirum Pharmaceuticals issued a press release on August 5, 2026, disclosing Q2 2026 financial results, including net product sales of $176.2 million and raising full-year guidance to $680–$700 million. The filing explicitly states this is a disclosure of "Results of Operations and Financial Condition" under Item 2.02, with the full press release furnished as Exhibit 99.1. This is a standard earnings release for a quarterly period.
View raw filing on EDGAR →Pennant Group issued a press release on August 5, 2026 reporting Q2 2026 financial results, including GAAP diluted EPS of $0.25, adjusted diluted EPS of $0.36, total revenue of $298.0 million (up 35.8% YoY), and net income of $9.1 million (up 28.2% YoY), along with updated 2026 guidance and detailed segment performance.
View raw filing on EDGAR →XPEL disclosed consolidated financial results for Q2 and six months ended June 30, 2026 via press release attached as Exhibit 99.1. The disclosure reports record revenue of $143.1 million (14.7% growth), net income of $18.0 million (10.7% growth), and EPS of $0.65, along with detailed financial statements and forward guidance for Q3 2026. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →Dynatrace announced first quarter fiscal 2027 financial results (ended June 30, 2026) with ARR of $2,136 million (17% growth), total revenue of $555 million (16% growth), and GAAP net income per share of $0.12, along with detailed financial highlights and forward guidance.
View raw filing on EDGAR →Arcutis reported Q2 2026 financial results with product revenues of $129.9 million (up 59% year-over-year) and net income of $15.0 million ($0.11 per share). The company raised its full-year 2026 guidance to $525–$540 million.
View raw filing on EDGAR →Root, Inc. announced its financial results for the quarter ended June 30, 2026, disclosing net income of $25 million (up 15% YoY), revenue of $389 million (up 2% YoY), adjusted EBITDA of $44 million (up 16% YoY), policies in force of 484 thousand (up 6% YoY), and a net combined ratio of 92.1%.
View raw filing on EDGAR →This is a clear earnings release disclosing Xperi's second quarter 2026 financial results for the period ended June 30, 2026. The Item 2.02 section explicitly states the company "announced its financial results for the second quarter ended June 30, 2026" with a press release furnished as Exhibit 99.1. The press release contains GAAP and non-GAAP financial highlights, revenue growth metrics (54% advertising revenue growth, 70% user growth), and updated guidance, all hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →